218 related articles for article (PubMed ID: 35798240)
1. Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment.
Park JV; Chandra R; Cai L; Ganguly D; Li H; Toombs JE; Girard L; Brekken RA; Minna JD
J Thorac Oncol; 2022 Oct; 17(10):1178-1191. PubMed ID: 35798240
[TBL] [Abstract][Full Text] [Related]
2. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
4. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage.
Pei JP; Wang Y; Ma LP; Wang X; Liu L; Zhang Y; Jin R; Ren ZQ; Deng Y; Shen JK; Meng T; Yu K
Acta Pharmacol Sin; 2023 Jun; 44(6):1290-1303. PubMed ID: 36650292
[TBL] [Abstract][Full Text] [Related]
5. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
6. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.
Liu L; Ge D; Ma L; Mei J; Liu S; Zhang Q; Ren F; Liao H; Pu Q; Wang T; You Z
J Thorac Oncol; 2012 Jul; 7(7):1091-100. PubMed ID: 22534817
[TBL] [Abstract][Full Text] [Related]
8. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
Kang H; Zhang J; Wang B; Liu M; Zhao J; Yang M; Li Y
Int J Oncol; 2017 Feb; 50(2):545-554. PubMed ID: 28101568
[TBL] [Abstract][Full Text] [Related]
9.
Xu YW; Xing RX; Zhang WH; Li L; Wu Y; Hu J; Wang C; Luo QL; Shen JL; Chen X
World J Gastroenterol; 2019 Dec; 25(45):6634-6652. PubMed ID: 31832003
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.
Chen T; Liu Y; Li C; Xu C; Ding C; Chen J; Zhao J
Cancer Treat Res Commun; 2021; 28():100412. PubMed ID: 34119765
[TBL] [Abstract][Full Text] [Related]
11. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content.
Gunalp S; Helvaci DG; Oner A; Bursalı A; Conforte A; Güner H; Karakülah G; Szegezdi E; Sag D
Front Immunol; 2023; 14():1209249. PubMed ID: 37809073
[TBL] [Abstract][Full Text] [Related]
12. [Regulatory effect of bone marrow mesenchymal stem cells on polarization of macrophages].
Hou Y; Zhou X; Cai WL; Guo CC; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):273-278. PubMed ID: 28494546
[No Abstract] [Full Text] [Related]
13. Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity.
Miret JJ; Kirschmeier P; Koyama S; Zhu M; Li YY; Naito Y; Wu M; Malladi VS; Huang W; Walker W; Palakurthi S; Dranoff G; Hammerman PS; Pecot CV; Wong KK; Akbay EA
J Immunother Cancer; 2019 Feb; 7(1):32. PubMed ID: 30728077
[TBL] [Abstract][Full Text] [Related]
14. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
15. [Macrophage colony stimulating factor enhances non-small cell lung cancer invasion and metastasis by promoting macrophage M2 polarization].
Li YJ; Yang L; Wang LP; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):412-418. PubMed ID: 28635229
[No Abstract] [Full Text] [Related]
16. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
[TBL] [Abstract][Full Text] [Related]
17. The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures.
Balážová K; Clevers H; Dost AFM
Elife; 2023 Feb; 12():. PubMed ID: 36809334
[TBL] [Abstract][Full Text] [Related]
18. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
20. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
